Henry Moore, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Ipsen Pharma
    Topic:
    Dystonia
    Date added:
    02/11/2026
    Date updated:
    02/11/2026
    Relationship end date:
    06/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Neurocrine
    Topic:
    Kinect HD and HD2 trial
    Date added:
    02/11/2026
    Date updated:
    02/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    MODUS Outcomes LLC
    Topic:
    UCB trial
    Date added:
    02/11/2026
    Date updated:
    02/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    CDHI Foundation
    Topic:
    Enroll HD trial
    Date added:
    02/11/2026
    Date updated:
    02/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Anneal Pharmaceuticals
    Topic:
    Elevate PD trial
    Date added:
    02/11/2026
    Date updated:
    02/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Abbvie Pharmaceuticals
    Topic:
    Dystonia and spasticity; Vyalev pump
    Date added:
    02/11/2026
    Date updated:
    02/11/2026
Return to Spasticity and Movement Disorders IMPACT Initiative (IMproving Patient Assessment and Chemodenervation Treatment